NICE type 2 diabetes guideline
This summary provides recommendations on blood glucose targets, patient education, and includes a useful algorithm on blood glucose management
![20200212 Guidelines comparison tablev10 [online] UPDATED 2020 v4](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/100x67//9/3/4/6934_20200212guidelinescomparisontablev10onlineupdated2020v4_419801.png)
Type 2 diabetes pharmacological management pathway comparison
This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN.
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.
SIGN type 2 diabetes guideline
This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm
Resource hub
Educational resources
Diabetes and frailty: guidance on the management of older adults with type 2 diabetes
Information intended for UK healthcare professionals only. This summary was developed by Guidelines and Dr Strain, based on the guidance developed by Strain WD et al., with the support of a sponsorship from Novo Nordisk UK.
Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes
In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3287 December 2020
Assessment of pancreatic exocrine insufficiency (PEI) in primary care
In this video, Professor Michael Cummings looks at the assessment of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3288 December 2020
Management of pancreatic exocrine insufficiency (PEI) in primary care
In this video, Professor Michael Cummings looks at the management of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3289 December 2020
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.